Laurence Rulleau

DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada.

adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada.

CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal.

Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada.

Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada.

Blackmont Capital Securities is the broker subsidiary of Blackmont Capital, Inc. They focus on sectors such as energy, metals and minerals, biotechnology and health services, technology and special situations, business trusts and industrials, consumer staples, real estate and hospitality and financial services. Blackmont screens for emerging influences, shifts in market dynamics and changes in corporate fundamentals to identify immediate growth opportunities with the best risk-reward profile

Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada.